Please assess the completion status of the following clinical trial:

Trial Title: Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Male or female aged 4 years to less than 18 years of age.~2. Individual who had a parent or guardian who could give written informed consent after understanding the nature of the study and comply with study procedures and were available for follow-up.~3. If the individual was of an age where, according to local regulations, informed assent is required, that individual had provided assent to participate in the study.~Exclusion Criteria:~1. Individuals recently vaccinated against influenza~2. Subjects with contraindications to receive influenza vaccine

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 18 Years
- Healthy Volunteers: t

Study Arms:
- QIVc (≥4 to <18 years) (Type: EXPERIMENTAL): Subjects received one or two doses of QIVc-Quadrivalent Cell-based Influenza Vaccine recommended for 2013-2014 season
- TIV1c (≥4 to <18 years) (Type: ACTIVE_COMPARATOR): Subjects received one or two doses of TIV1c (Trivalent Inactivated Cell-based Influenza Vaccine containing one strain from B lineage (B1 strain) recommended for 2013-2014 season
- TIV2c (≥4 to <18 years) (Type: ACTIVE_COMPARATOR): Subjects received one or two doses of TIV2c (Trivalent Inactivated Cell-based Influenza Vaccine containing B strain from the alternate lineage (B2 strain) recommended for 2013-2014

Based on this trial design, predict the completion outcome and termination type (if applicable).